Lipidomic Profiling Links the Fanconi Anemia Pathway to Glycosphingolipid Metabolism in Head and Neck Cancer Cells. Clinical Cancer Research. 2018; 24(11):2700-2709.
Dek overexpression in murine epithelia increases overt esophageal squamous cell carcinoma incidence. PLoS Genetics. 2018; 14(3):e1007227.
Risk of Human Papillomavirus Infection in Cancer-Prone Individuals: What We Know. Viruses. 2018; 10(1).
Cancer Cell Metabolism: Implications for X-ray and Particle Radiation Therapy. International Journal of Particle Therapy. 2018; 5(1):40-48.
Limited detection of human polyomaviruses in Fanconi anemia related squamous cell carcinoma. PLoS ONE. 2018; 13(12):e0209235.
The nuclear DEK interactome supports multi-functionality. Proteins: Structure, Function and Bioinformatics. 2018; 86(1):88-97.
DEK associates with tumor stage and outcome in HPV16 positive oropharyngeal squamous cell carcinoma. Oncotarget. 2017; 8(14):23414-23426.
DEK is required for homologous recombination repair of DNA breaks. Scientific Reports. 2017; 7:44662.
Overexpression of the human DEK oncogene reprograms cellular metabolism and promotes glycolysis. PLoS ONE. 2017; 12(5):e0177952.
Overcoming Pluripotent Stem Cell Dependence on the Repair of Endogenous DNA Damage. Stem Cell Reports. 2016; 6(1):44-54.
DEK promotes mammary hyperplasia and is associated with H3K27me3 epigenetic modifications. Life Science Alliance. 2025; 8(9).
The Fanconi Anemia Pathway Inhibits mTOR Signaling and Prevents Accelerated Translation in Head and Neck Cancer Cells. Cancers. 2025; 17(15).
Phase 1 study of quercetin, a natural antioxidant for children and young adults with Fanconi anemia. Blood advances. 2025; 9(8):1927-1939.
A Single-Cell Transcriptome Atlas of Epithelial Subpopulations in HPV-Positive and HPV-Negative Head and Neck Cancers. Viruses. 2025; 17(4).
Fanconi anemia neuroinflammatory syndrome: brain lesions and neurologic injury in Fanconi anemia. Blood advances. 2024; 8(12):3027-3037.
Lipid profiling of RON and DEK-dependent signaling in breast cancer guides discovery of gene networks predictive of poor outcomes. Frontiers in Oncology. 2024; 14:1382986.
RUNX1 mutations mitigate quiescence to promote transformation of hematopoietic progenitors in Fanconi anemia. Leukemia. 2023; 37(8):1698-1708.
Fanconi anemia-isogenic head and neck cancer cell line pairs: A basic and translational science resource. International Journal of Cancer. 2023; 153(1):183-196.
RON-augmented cholesterol biosynthesis in breast cancer metastatic progression and recurrence. Oncogene. 2023; 42(21):1716-1727.
Single cell transcriptomic analysis of HPV16-infected epithelium identifies a keratinocyte subpopulation implicated in cancer. Nature Communications. 2023; 14(1):1975.
Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer. Nature. 2022; 612(7940):495-502.
Head and Neck Cancer Susceptibility and Metabolism in Fanconi Anemia. Cancers. 2022; 14(8).
Detection of cytogenetic changes and chromosomal aneuploidy with fluorescent in situ hybridization in cytological specimens of oral cancers in Fanconi anemia-Proof of concept. Clinical and Experimental Dental Research. 2022; 8(1):108-116.
BIRC2-BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia. Scientific Reports. 2022; 12(1):45.
NMR-based metabolomic analysis identifies RON-DEK-β-catenin dependent metabolic pathways and a gene signature that stratifies breast cancer patient survival. PLoS ONE. 2022; 17(9):e0274128.